Skip to content

Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery

Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery: A Pilot Study

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05971173
Enrollment
40
Registered
2023-08-02
Start date
2023-09-28
Completion date
2025-06-04
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures

Keywords

Older adults, Hip surgery

Brief summary

The overall objective of this pilot study is to test a comprehensive nutritional intervention in elderly patients diagnosed with hip fracture, which the study team believe will reduce functional decline, morbidity and mortality.

Detailed description

This collaborative pilot study is led by a PI who is a board-certified orthopaedic surgeon with extensive experience in the care of older adults with hip fractures. In addition, the multidisciplinary study team includes a research health scientist with vast experience in nutrition, preventive health, and gerontology. The study team will also be supported by a physical therapist and researcher in the field of rehabilitation of older adults with musculoskeletal disorders. Furthermore, an occupational therapist with expertise in rehabilitation science, conduct of pilot studies, and analysis of interview data will play an important role in this study. Moreover, the statistical analyses will be performed by an expert statistical consultant from our institution, who will be reimbursed on a fee for service basis.

Interventions

DRUGJuven

Nutritional supplements

DRUGCentrum Silver 50+

Over the counter nutritional supplement

Sponsors

The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

1. Provision of signed and dated informed consent form 2. Male or female, aged 65-89 years 3. Closed fracture of the proximal femur including the anatomic areas of femoral neck, intertrochanteric and subtrochanteric region 4. Patient indicated for surgical treatment (surgical fixation or arthroplasty) as per orthopaedic surgeon 5. Ability to take oral medication and be willing to adhere to the study drug regimen and to the nutritional guidance provided by nutritional experts.

Exclusion criteria

1. Patients with open fractures 2. Surgical treatment other than surgical fixation or arthroplasty, such as proximal femur resection 3. Known allergic reactions to components of the study drugs or who do not tolerate oral nutritional supplementation (e.g. total parenteral nutrition or food allergies) 4. Decisional impairment 5. Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Assessment of surgical complications at 26 weeks26 weeks (post surgery)Number of subjects that experienced any complications post surgery

Secondary

MeasureTime frameDescription
Hospital Readmissions26 weeks (post surgery)Number of hospital re-admissions
Secondary fractures26 weeks (post surgery)Number of secondary fractures that occurred post surgery
Grip strengthBaseline to 26 weeksChange in grip strength from pre- to post-surgery using a hand dynamometer and measured in pounds
Quality of Life Survey (Short-form 36 Health (SF-36))Baseline to 26 weeksChange in Health related quality of life (QOL) survey, a 36 item survey. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBoris Zelle, MD

The University of Texas Health Science Center at San Antonio

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 24, 2026